🏅 FDA Orphan Designation
Sylatron
peginterferon alfa-2b
Manufacturer: Merck, Sharpe & Dohme Corp.
Indicated for:📚 Malignant melanoma of the mucosa
Indications & Usage
Adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy
💙 Support Programs
View all →Sylatron
Merck, Sharpe & Dohme Corp.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.